Welcome to Broadline Capital
Broadline Capital is a global alternative investment firm focused primarily on growth capital and strategic support for category leaders and category creators that are reshaping their industry. Founded two decades ago by Chris Thorne, the firm has developed a track record of selecting successful companies and leading some of the most creative deals in the history of their category.
At Broadline, we are inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their ideas into the next big, industry-changing company. Broadline seeks purpose-driven companies with large addressable markets that represent promising commercial opportunities.
We place emphasis on companies positioned to create broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of a more efficient, sustainable, and healthier way of life.
Broadline's principals have spent their entire careers building trust-based relationships globally. Most have built and led successful companies and negotiated quality exits on behalf of themselves and their investors. Broadline aims to support its portfolio companies through its unique access to domain expertise, pragmatic operating experience, and a vast network of relationships built over many years. We believe our current opportunities are among the most exciting on the planet.
​
New York | Miami | San Diego | Boulder | Columbus | Seoul | Shanghai | London
Our Approach
Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain. Our investment team seeks diversification by investing across a range of industries, geographies, transaction structures, and market capitalizations. When selecting opportunities, we take a two-pronged approach:
​
-
First, our investment team starts with a "Top-Down" approach to identify Core Thematic Categories, where the combination of strong margins, industry growth, and broad impact are creating an abundance of opportunities with Large Addressable Markets.
​
-
Next, we take a "Bottom-Up" approach to screen for companies within these Core thematic Categories that are tracking to become Category Leaders or Category Creators, placing emphasis on expected near-term liquidity events or valuation milestones, such as an IPO or M&A event.
Portfolio Highlights
Areas of Focus
-
Energy & Environment. Applying creative business models that can help accelerate the transformation of industries and bring the world together to reduce Greenhouse Gas (GHG) Pollution.
​
-
Purpose-driven Technologies. Advancing tools that address unmet needs for increased Efficiency, Precision, Convenience, Accessibility, Data Management, and Data Security.
​​
-
Financial Services. Unlocking value-added digital services that offer Smarter, Faster, and More Accessible financial solutions.
​
-
Healthy Life. Advancing novel therapeutic platforms, synthetic biologics, AI-driven innovations, robotics, and less-invasive medical devices to improve Patient Outcomes.
​
-
Food Security. Upgrading the Food Ecosystem by improving Production Efficiency, Supply Chain Resilience, Cold Storage, Source Traceability, Ingredient Transparency, Food Security, and conversion of Food Waste into Biofuel.
​
We invite you to scroll through case examples below. If you're a Broadline-registered investor, please click on the "Investor Login" tab at the top of this website for management reports from portfolio companies.
Healthy Life
GLP-1 Amplifier VIA NOVEL ENDOSCOPIC PLATFORM
EndoSphere is a clinical-stage medical technology company that developed a first-in-class platform to treat metabolic diseases targeting one of the world's largest and fastest-growing healthcare categories: Obesity and its Co-Morbidities, including Fatty Liver Disease. EndoSphere's novel "Endo-Metabolic" platform presents a completely new category. It is the first to uniquely focus on the Duodenum, the upper intestinal organ widely recognized for its numerous functions as the body's Metabolic Control Center.
Endosphere's flagship GLP-1 anti-obesity device, called KB-21, is incisionless, reversible and repeatable. Clinical studies have shown that it measurably amplifies GLP-1 levels, curbing appetite naturally, and enabling Obese patients to achieve significant Excess Weight Loss. It provides an alternative to riskier treatment alternatives experienced by patients who suffer from Gastroparesis caused by synthetic GLP-1 drugs. Unlike restrictive devices and bariatric surgeries, which work by constricting the structural capacity of the stomach, EndoSphere works at a physiological level by triggering the body to amplify its own GLP-1 and CKC metabolic hormonal responses to food intake. Unlike synthetic GLP-1 drugs, EndoSphere has not caused Gastroparesis disease in any patients.
The result: A more natural approach to accelerate Satiation by recalibrating the brain-gut metabolic feedback loops, while also rebalancing insulin levels. EndoSphere's proprietary technologies and patented solutions are 100% company-owned (free from any third-party licensing or royalty obligations). EndoSphere's industry recognitions include the "Fierce15" award, recognizing it among "the world's most promising privately-held medical innovations." For more information, please visit https://www.Endo-sphere.com.
Energy & Environment
Carbon-Free Lithium-ion and Solid State BatterY CATHODES
Founded in January 2010, Powermers, Inc. was an energy storage innovator and advanced materials company headquartered in Columbus, Ohio. The company developed proprietary energy storage innovations that created safer, higher-performing batteries. The company was sold to Ares Smart Industries in December 2023, and the combined company was renamed: Powermers Smart Industries, Inc. ("PSI"). The acquired company had created fundamental advancements in lithium-ion and solid state battery cathode technologies. Powermers' drop-in technology was tailor-made for efficient adoption by established battery manufacturers. By replacing inactive materials (including the battery's Carbon, Binders and Solvents) with patented higher-performing nano-scale conductive polymer coatings, Powermers' patented battery technology achieved highly differentiated results in both safety and performance. Powermers' fundamental advancements in cathode technology were independently-tested and validated by multiple university labs and government labs (CERL) around the world, including the Center for Automotive Research at The Ohio State University. These validated results in scaled pouches were published in industry peer-review publications, including American Chemical Society's Applied Materials & Interfaces, demonstrating their proprietary transition-metal polymers to be a scientific breakthrough, representing higher catalytic functionality than pure noble-metal catalysts including gold, platinum, and palladium.
​
7 advantages of Powermers' patented battery technology platform:
1. Safety: Mitigates Thermal Runaway Risk (the prevailing cause of combustion in high-voltage Lithium-ion batteries).
2. Toxicity: Reduces reliance on costly Toxic Solvents frequently used in battery manufacturing processes.
3. Energy ("How far you can go"): Expands Active Material Limits by replacing inactive materials with conductive polymers.
4. Power ("How fast you can go"): No sacrifice of Power is necessary.
5. Cycle Life ("How long your battery lasts"): No sacrifice of Cycle Life is necessary.
6. Ease of Adoption ("Drop-in Technology"): Enables rapid acceptance into existing battery manufacturing processes.
7. Cost per KWH: Reduces Total Cost per KWH by eliminating reliance on costly solvents while enabling increased energy.
For more information, please visit https://www.Powermers.com.
Our Team
Broadline Capital's principals and venture partners have spent their entire careers building trust-based relationships globally. They understand what it takes to align multiple stakeholders toward a shared vision, then develop a clear plan and work together to execute it...because they've done it multiple times.
Broadline's principals love going back to their roots as entrepreneurs. Most of Broadline's principals are past CEOs and entrepreneurs who created significant value in their prior companies. They excelled in their past careers at top institutions such as McKinsey, Morgan Stanley, General Electric, Apple, Brunswick, Oppenheimer, PwC, Allergan, Pfizer, and Roche. They trained and taught at the world's leading educational and research institutions. They collectively received 46 academic degrees - including 21 advanced degrees and 11 doctorates.
This combined experience, expertise and network of relationships help contribute to Broadline's current and future companies.
Contact
"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are working to transform their ideas into the next big, industry-changing company." If you share our perspective, we invite you to join us."
